EDGAR Filing Documents for 0000810509-15-000003

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0000810509-15-000003

Filing Date

2015-03-16

Accepted

2015-03-16 15:02:35

Documents

Period of Report

2014-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-K	navb1231201410k.htm	10-K	2909684
2	EXHIBIT 21.1	navb12312014ex21-1subsidia.htm	EX-21.1	5928
3	EXHIBIT 23.1	navb12312014ex23-1consent.htm	EX-23.1	3732
4	EXHIBIT 24.1	navb12312014ex24-1powerofa.htm	EX-24.1	11877
5	EXHIBIT 31.1	navb12312014ex31-1.htm	EX-31.1	9858
6	EXHIBIT 31.2	navb12312014ex31-2.htm	EX-31.2	9867
7	EXHIBIT 32.1	navb12312014ex32-1.htm	EX-32.1	5138
8	EXHIBIT 32.2	navb12312014ex32-2.htm	EX-32.2	5148
15		navb123120_chart-37866a01.jpg	GRAPHIC	66404
	Complete submission text file	0000810509-15-000003.txt		13413363

Data Files

Seq	Description	Document	Type	Size
9	XBRL INSTANCE DOCUMENT	navb-20141231.xml	EX-101.INS	1555640
10	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT	navb-20141231.xsd	EX-101.SCH	76730
11	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT	navb-20141231_cal.xml	EX-101.CAL	85231
12	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT	navb-20141231_def.xml	EX-101.DEF	388884
13	XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT	navb-20141231_lab.xml	EX-101.LAB	972153
14	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT	navb-20141231_pre.xml	EX-101.PRE	566431

Mailing Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017

Business Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017 6147937500

NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)